Related Experiment Video

Updated: Mar 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.1K

Status quo of p53 in the treatment of tumors

Yong-Song Guan1, Qing He, Qing Zou

  • 1aDepartment of Oncology, West China Hospital of Sichuan University bState Key Laboratory of Biotherapy, West China Medical School, Sichuan University, Chengdu, Sichuan Province, China.

Anti-Cancer Drugs
|July 8, 2016
PubMed

Insights

The p53 tumor suppressor gene is crucial in cancer development. This review examines p53-targeted cancer therapies, highlighting challenges and future directions for personalized treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • The p53 gene plays a critical role in preventing oncogenesis.
  • Loss of the p53 pathway is common in human cancers, driving interest in p53-targeted therapies.
  • Current therapeutic strategies targeting p53 are debated, with approaches aiming to both activate and inhibit p53.

Purpose of the Study:

  • To review and clarify controversies surrounding p53-targeted cancer therapies.
  • To evaluate available technological protocols for p53-based cancer management.
  • To identify future research directions for improving antitumor studies involving p53.

Main Methods:

  • Literature review of current research on p53-targeted cancer therapies.
  • Analysis of technological protocols for exogenous p53 addition.
  • Evaluation of the advantages and limitations of various p53 therapeutic strategies.

Main Results:

  • Conflicting approaches exist for p53-targeted cancer therapies, focusing on both activation and inhibition.
  • Exogenous p53 addition is a viable strategy due to p53 loss in many cancers.
  • The efficacy of p53 therapy varies by cell type, necessitating individualized treatment approaches.

Conclusions:

  • Personalized p53 therapy tailored to individual cell types is the future direction for cancer treatment.
  • Further research is needed to refine technological protocols and overcome limitations in p53-based cancer management.
  • Clarifying controversies and understanding p53's diverse roles are essential for advancing antitumor strategies.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

311
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

11.6K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K